• Kaplan JE, Benson C, , Brooks JT, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207.  (Leishmaniasis chapter found on pages 99-103.)
• Global Disease Elimination and Eradication as Public Health Strategies (December 31, 1999 / Vol. 48 / Supplement)
• Unexplained Illness Among Persian Gulf War Veterans in an Air National Guard Unit: Preliminary Report -- August 1990-March 1995 (June 16, 1995 / 44(23);443-447) 
• Viscerotropic Leishmaniasis in Persons Returning from Operation Desert Storm -- 1990 - 1991 (February 28, 1992 / 41(08);131-134)
• Cutaneous Leishmaniasis -- Ohio (August 23, 1985 / 34(33);515-6) 

Back To Top

• Hospitalizations after the Gulf-War–Reply to K.M. Leisure et al. (Vol. 4, No. 4 | October-December 1998)
• Hospitalizations after the Gulf-War (Vol. 4, No. 4 | October-December 1998) 
• Emerging Infectious Diseases--Brazil (Vol. 4./No. 1 January-March 1998)
• The Reemergence of Visceral Leishmaniasis in Brazil (Vol. 2/No. 2 | April-June 1996)

Back To Top

• Sousa A, Frutuoso M, Moraes E, Pearson R, Pompeu M. High-Dose Oral Fluconazole Therapy Effective for Cutaneous Leishmaniasis Due to Leishmania (Vianna) braziliensis. Clin Infect Dis. 2011. 53 (7): 693-695.
• Wortmann G, Zapor M, Ressner R, Fraser S, Hartzell J, Pierson J, Weintrob A, Magill A. Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis. Am J Trop Med Hyg 2010 83: 1028-1033.
• Gonzalez U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA, 2009. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev: CD004834.
• Bern C, Maguire JH, Alvar J, 2008. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2: e313.
• Gonzalez U, Pinart M, Reveiz L, Alvar J, 2008. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev: CD005067.
• Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V, 2008. Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. Int J Dermatol 47: 109-24.
• Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Neto VA, 2007. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 77: 266-74.
• Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581-96.
• Alvar J, Croft SL, Olliaro P, 2006. Chemotherapy in the treatment and control of leishmaniasis. Advances in Parasitology 61: 227-279.
• Alvar J, Yactayo S, Bern C, 2006. Leishmaniasis and poverty. Trends Parasitol 22: 552-7.
• Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J, 2006. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 43: 917-24.
• Murray HW, Berman JD, Davies CR, Saravia NG, 2005. Advances in leishmaniasis. Lancet 366: 1561-77.
• Laguna F, 2003. Treatment of leishmaniasis in HIV-positive patients. Ann Trop Med Parasitol 97 Suppl 1: 135-42.

Back To Top

• Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
• Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.
• Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996;14:417-23.
• Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 1993;118:779-84.

Back To Top